Close

Analyst Ratings for Actus Medical (AFIB) [Buys]

AFIB Rating Summary

AFIB Price Target Summary

* Over Last 12-Mos
  |   Expand Research on AFIB
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $0.74 (+289.5%) * Over Last 12-Mos
Rating Score: 2.9 / 10   Percentile Rank: 24%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/27/2022 BTIG
» Updated 8/12/2022
Marie Thibault Upgrade Buy
(Neutral)
2.50
(1.50)
0.80
(0.19)
-76.25% Details
12/15/2021 Spartan Capital Javier Fonseca New Coverage Buy
(N/A)
9.00
(N/A)
3.20
(0.19)
-94.06% Details